Elevated Risk of Developing Breast Cancer
Also known as: Increased Risk for Development of Breast Cancer / High Risk for Developing Breast Cancer / High Risk of Breast Cancer / High Risk for Breast Cancer / High-Risk Breast Cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09074 | Olaparib | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. |
| DB00481 | Raloxifene | A selective estrogen receptor modulator that is used to prevent and treat osteoporosis and reduce the risk of invasive breast cancer in high-risk postmenopausal women. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06401 | Bazedoxifene | 0 | Active Not Recruiting | 1 |
| DB00286 | Conjugated estrogens | 0 | Active Not Recruiting | 1 |